— Know what they know.
Not Investment Advice

KLRS Smart Money

Kalaris Therapeutics Inc
1W: -7.5% 1M: -30.8% 3M: -41.9% YTD: -67.5% 1Y: -55.5%
$2.70
-0.15 (-5.26%)
 
Weekly Expected Move ±5.8%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $58.9M mcap · 7M float · 2.81% daily turnover · Short 49% of daily vol

🏦 Institutional Activity

Latest: Q2 2026
68
Institutions Holding
+3 vs prior
124.6%
Ownership
-57.32%
10 New
18 Increased
20 Reduced
12 Closed

👔 Insider Trades

25 records
Date Name Title Type Shares Price Value Filing
2026-05-20 Samsara Opportunity Fund GP, LLC 10% owner J-J 4,471 $— $0 Filing
2026-05-20 AKKARAJU SRINIVAS director J-J 4,471 $— $0 Filing
2026-05-20 Samsara Opportunity Fund GP, LLC 10% owner J-J 14,937 $— $0 Filing
2026-05-20 Samsara Opportunity Fund, L.P. 10% owner J-J 4,471 $— $0 Filing
2026-05-20 Samsara BioCapital GP, LLC 10% owner J-J 4,471 $— $0 Filing
2026-05-20 AKKARAJU SRINIVAS director P-Purchase 244,300 $4.83 $1.2M Filing
2026-05-20 Samsara BioCapital, L.P. 10% owner P-Purchase 244,300 $4.83 $1.2M Filing
2026-05-20 Samsara BioCapital, L.P. 10% owner J-J 4,471 $— $0 Filing
2026-05-20 Samsara Opportunity Fund, L.P. 10% owner P-Purchase 244,300 $4.83 $1.2M Filing
2026-05-20 Samsara Opportunity Fund GP, LLC 10% owner P-Purchase 244,300 $4.83 $1.2M Filing
2026-05-20 AKKARAJU SRINIVAS director J-J 66,906 $— $0 Filing
2026-05-20 Samsara BioCapital, L.P. 10% owner J-J 66,906 $— $0 Filing
2026-05-20 Samsara BioCapital GP, LLC 10% owner J-J 66,906 $— $0 Filing
2026-05-20 Samsara Opportunity Fund, L.P. 10% owner J-J 66,906 $— $0 Filing
2026-05-20 Samsara Opportunity Fund GP, LLC 10% owner J-J 66,906 $— $0 Filing
2026-05-20 AKKARAJU SRINIVAS director J-J 14,937 $— $0 Filing
2026-05-20 Samsara BioCapital, L.P. 10% owner J-J 14,937 $— $0 Filing
2026-05-20 Samsara BioCapital GP, LLC 10% owner J-J 14,937 $— $0 Filing
2026-05-20 Samsara Opportunity Fund, L.P. 10% owner J-J 14,937 $— $0 Filing
2026-05-20 Samsara BioCapital GP, LLC 10% owner P-Purchase 244,300 $4.83 $1.2M Filing
2025-12-22 AKKARAJU SRINIVAS director A-Grant/Award 1,500,000 $10.00 $15.0M Filing
2025-12-22 Samsara Opportunity Fund, L.P. 10% owner A-Grant/Award 1,500,000 $10.00 $15.0M Filing
2025-12-22 Samsara Opportunity Fund GP, LLC 10% owner A-Grant/Award 1,500,000 $10.00 $15.0M Filing
2025-12-18 Samsara BioCapital, L.P. 10% owner P-Purchase 479,847 $10.42 $5.0M Filing
2025-12-18 AKKARAJU SRINIVAS director P-Purchase 479,847 $10.42 $5.0M Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

20 holders
Holder Shares Value Date Reported Filing
SAMSARA BIOCAPITAL, LLC 12,881,175 $52M -66,906 2026-06-30 Filing
RTW INVESTMENTS, LP 1,300,000 $5M — 2026-06-30 Filing
Alyeska Investment Group, L.P. 572,687 $2M — 2026-06-30 Filing
Siren, L.L.C. 435,798 $2M — 2026-06-30 Filing
VANGUARD CAPITAL MANAGEMENT LLC 398,712 $2M +143,364 2026-06-30 Filing
Ikarian Capital, LLC 360,000 $1M — 2026-06-30 Filing
UBS Group AG 262,131 $1M +255,947 2026-06-30 Filing
RENAISSANCE TECHNOLOGIES LLC 149,351 $608K +83,200 2026-06-30 Filing
MARSHALL WACE, LLP 139,201 $567K +71,322 2026-06-30 Filing
GEODE CAPITAL MANAGEMENT, LLC 114,037 $464K +26,492 2026-06-30 Filing
ADAR1 Capital Management, LLC 100,000 $407K — 2026-06-30 Filing
Woodline Partners LP 100,000 $407K — 2026-06-30 Filing
WHI TRUST Co LLC 97,493 $397K — 2026-06-30 Filing
RAYMOND JAMES FINANCIAL INC 97,164 $395K -21,723 2026-06-30 Filing
CITADEL ADVISORS LLC 95,772 $390K +95,772 2026-06-30 Filing
BOOTHBAY FUND MANAGEMENT, LLC 92,261 $376K — 2026-06-30 Filing
Verdad Advisers, LP 80,297 $327K +80,297 2026-06-30 Filing
MORGAN STANLEY 72,326 $294K +33,982 2026-06-30 Filing
VANGUARD FIDUCIARY TRUST CO 66,179 $269K +29,462 2026-06-30 Filing
BlackRock, Inc. 54,442 $222K +18,399 2026-06-30 Filing

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms